Tarceva.com
| Top tarceva sites |
- Title
- Tarceva® (erlotinib) Tablets for Advanced-Stage NSCLC & Advanced-Stage Pancreatic Cancer
- Meta Description
- Discover Tarceva® (erlotinib) Tablets, a treatment for advanced-stage non-small cell lung cancer (NSCLC) and advanced-stage pancreatic cancer. Who is Tarceva for? Tarceva is approved as a 1st-line treatment, maintenance treatment, and 2nd- or 3rd-line treatment for advanced-stage non-small cell lung cancer (NSCLC). Tarceva is prescribed as initial treatment for patients with NSCLC whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations. (1st-line treatment) Tarceva is prescribed as maintenance treatment for advanced-stage NSCLC in patients whose cancer has not spread or grown after prior treatment with certain types of chemotherapy. Tarceva is prescribed as 2nd- or 3rd-line treatment for advanced-stage NSCLC in patients whose cancer has spread or grown after receiving at least one round of chemotherapy. Tarceva is not meant to be used at the same time as certain types of chemotherapy for advanced NSCLC. For ...
- Meta Keywords
| Expires | Sun, 19 Nov 1978 05: |
| Last-Modified | Sat, 07 Nov 2015 04: |
| Cache-Control | no-cache, must-reval |
| ETag | "1446869029" |
| Content-Language | en |
| Content-Type | text/html; charset=u |
| Content-Length | 68489 |
| Accept-Ranges | bytes |
| X-Varnish | 1014387399 |
| Age | 0 |
| Connection | keep-alive |
| X-Cache | MISS |